Regenacy Pharmaceuticals, Inc.
Edit

Regenacy Pharmaceuticals, Inc.

https://regenacy.com/
Tags:BioTechManagementMedtechResearch
Regenacy Pharmaceuticals is developing a novel, disease-modifying approach to treating peripheral neuropathies that goes beyond pain and symptom management to restore peripheral nerve function. Our lead compound ricolinostat (ACY-1215) is an oral, selective inhibitor of the microtubule modifying enzyme HDAC6 with first-in-class potential, currently positioned to enter Phase 2 clinical trials. Our investigation of ricolinostat for diabetic, chemotherapy-induced and inherited peripheral neuropathies is based on compelling proof-of-concept preclinical studies demonstrating restoration of normal nerve function. We were founded in December 2016 following the acquisition of Acetylon Pharmaceuticals by Celgene. Regenacy received exclusive rights to ricolinostat, a clinical stage, orally bioavailable, HDAC6 selective inhibitor, for a range of non-cancer disease indications. We also have a unique and proprietary portfolio of selective HDAC1,2 inhibitors with potential for treating cancer, hemoglobinopathies, and cognitive dysfunction.
Location: United States, Massachusetts, Waltham
Member count: 1-10
Total raised: $39.3M
Founded date: 2016

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
25.08.2022Series B$9.3M-vcnewsdail...
25.03.2020Series A$30M-3ebiovc.co...

Mentions in press and media 12

DateTitleDescriptionCategoryAuthorSource
28.09.2022Portfolio ...SHANGHAI, Sept. 28, 2022 /PRNe...--en.prnasia...
25.08.2022Regenacy P... WALTHAM, MA, Regenacy Pharma...--vcnewsdail...
27.03.2020These heal...Headquarters: Neuchatel, Switz...--medcitynew...
26.03.2020Regenacy P...---3ebiovc.co...
25.03.2020Regenacy P...Regenacy Pharmaceuticals, a Wa...USA-finsmes.co...
25.03.2020Regenacy P...Treatments for diabetic periph...Biotech-fiercebiot...
25.03.2020Cobro Vent...WALTHAM, Mass.--(BUSINESS WIRE...--citybizlis...
25.03.2020Regenacy P...WALTHAM, Mass.--(BUSINESS WIRE...--citybizlis...
25.03.2020Regenacy P...Treatments for diabetic periph...Biotech-fiercebiot...
25.03.2020Regenacy P... WALTHAM, MA, Regenacy Pharma...--vcnewsdail...
Show more